Early studies on correcting the ASXL1 mutation in the CML cell line KBM5 has already confirmed the restoration of gene function and prolonger survival of xenograft mouse models (Valletta et al., 2015). Here, ASXL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.